(1)
Nesen, A.; Savicheva, K.; Semenovykh, P.; Galchiskaya, V. Vasopressin Marker Copeptin and the Development of Renal and Metabolic Disorders in Patients With Type 2 Diabetes. Ukr. J. Nephrol. Dial. 2022, 55-62.